Çokgezer, S. et al. 2026. Hematologic Toxicity During First-Line Platinum-Based Chemotherapy in BRCA-Mutated Ovarian Cancer: Predictors and Survival Impact. Cerrahpaşa Medical Journal. 50, (Jul. 2026), 1–8. DOI:https://doi.org/10.5152/cjm.2026.26033.